Patents by Inventor Paul O'Sullivan
Paul O'Sullivan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11963694Abstract: A thrombectomy device for removing thrombus from a body lumen comprises an elongated catheter member (2) having a distal part and a proximal part, a thrombus blocking body (5) disposed on the distal part of the catheter member and radially expansible between a contracted orientation and an expanded, thrombus-blocking, orientation, a thrombus capture body (3) disposed on the distal part of the catheter member in an axially spaced-apart relationship to the thrombus blocking body, and radially expansible between a contracted orientation and an expanded, thrombus-capture, orientation, deployment means actuable to deploy and retract the thrombus capture body and thrombus blocking body; and an elongated control arm operably connected to the thrombus capture body. The thrombus capture body is a cage having an inwardly tapering leading end, the elongated control arm is operably connected to the leading end of the cage, and a thrombus extractor or macerator mechanism is disposed within the cage.Type: GrantFiled: July 2, 2020Date of Patent: April 23, 2024Assignee: Vetex Medical LimitedInventors: Mark Bruzzi, Paul Heneghan, Saeid Kasiri Ghahi, Gerard O'Sullivan
-
Patent number: 11532934Abstract: Digital isolator devices, and many other devices, have a maximum device junction temperature, which, if exceeded, may cause device failure and the integrity of the isolation is no longer guaranteed. The use of an electronic fuse, eFuse, arranged in series with the digital isolator, provides a protection scheme for the digital isolator in which current is limited by the eFuse when it is determined that the supply current of the digital isolator exceeds a predetermined threshold that would the cause junction temperature to increase above an absolute maximum rating. As such, the integrity of the digital isolator is preserved in the event of a system fault.Type: GrantFiled: November 29, 2018Date of Patent: December 20, 2022Assignee: Analog Devices International Unlimited CompanyInventors: Paul O'Sullivan, Maurice O'Brien, Donal G. O'Sullivan, Stefan Hacker, Conal Watterson
-
Patent number: 11467327Abstract: The present disclosure provides numerous applications for the use of liquid crystal polarization gratings (LCPGs) to controllably steer light. When combined with an image sensor, light generated or reflected from different fields of view (FOV) can be steered, allowing an increase in the FOV or the resolution of the image. Further, the LCPG can stabilize the resulting image, counteracting any movement of the image sensor. The combination of LCPGs and liquid crystal waveguides (LCWGs) allows fine deflection control of light (from the LCWG) over a wild field of view (from the LCPG). Further applications of LCPGs include object tracking and the production of depth images using multiple imaging units and independently steered LCPGs. The LCPG may be used in controlling both the projection and reception of light.Type: GrantFiled: February 17, 2020Date of Patent: October 11, 2022Assignee: Analog Devices International Unlimited CompanyInventors: Eoin E. English, Andrew William Sparks, Scott Robert Davis, Tyler Adam Dunn, Maurizio Zecchini, Michael Ziemkiewicz, Ronald A. Kapusta, Javier Calpe Maravilla, Paul O'Sullivan, Jonathan Ephraim David Hurwitz, Erik D. Barnes, Monica Redon Segrera, Krystian Balicki
-
Publication number: 20220122243Abstract: There is presented a system and method for detecting mobile device fault conditions, including detecting fault conditions by software operating on the mobile device. In one embodiment, the present invention provides for systems and methods for using a neural network to detect, from an image of the device, that the mobile device has a defect, for instance a cracked or scratched screen. Systems and methods also provide for, reporting the defect status of the device, working or not, so that appropriate action may be taken by a third party.Type: ApplicationFiled: December 27, 2021Publication date: April 21, 2022Inventors: William Fitzgerald, Donal O'Shaughnessy, Donie Kelly, Paul O'Sullivan, Liam O'Callaghan, James Donovan, Shane Hallinan, Charlie McGrory, Wayne Morgan, Uday Chitturi, Patrick Conway, John Mollaghan, Kevin Sutton
-
Patent number: 11208698Abstract: Embodiments of this invention include methods for detection of markers of bladder cancer and inflammatory conditions of the bladder. Particularly, methods include detection of expression of certain genetic markers for bladder cancer and markers for detection of inflammatory conditions of the bladder. These methods provide improved detection of the markers, and provide better detection of bladder cancer and inflammatory conditions of the bladder.Type: GrantFiled: May 24, 2018Date of Patent: December 28, 2021Assignee: PACIFICEDGE LIMITEDInventors: Parry John Guilford, Mark Dalphin, Laimonis Kavalieris, Paul O'Sullivan
-
Patent number: 11210777Abstract: There is presented a system and method for detecting mobile device fault conditions, including detecting fault conditions by software operating on the mobile device. In one embodiment, the present invention provides for systems and methods for using a neural network to detect, from an image of the device, that the mobile device has a defect, for instance a cracked or scratched screen. Systems and methods also provide for, reporting the defect status of the device, working or not, so that appropriate action may be taken by a third party.Type: GrantFiled: February 19, 2018Date of Patent: December 28, 2021Assignee: BLANCCO TECHNOLOGY GROUP IP OYInventors: William Fitzgerald, Donal O'Shaughnessy, Donie Kelly, Paul O'Sullivan, Liam O'Callaghan, James Donovan, Shane Hallinan, Charlie McGrory, Wayne Morgan, Uday Chitturi, Patrick Conway, John Mollaghan, Kevin Sutton
-
Publication number: 20200271841Abstract: The present disclosure provides numerous applications for the use of liquid crystal polarization gratings (LCPGs) to controllably steer light. When combined with an image sensor, light generated or reflected from different fields of view (FOV) can be steered, allowing an increase in the FOV or the resolution of the image. Further, the LCPG can stabilize the resulting image, counteracting any movement of the image sensor. The combination of LCPGs and liquid crystal waveguides (LCWGs) allows fine deflection control of light (from the LCWG) over a wild field of view (from the LCPG). Further applications of LCPGs include object tracking and the production of depth images using multiple imaging units and independently steered LCPGs. The LCPG may be used in controlling both the projection and reception of light.Type: ApplicationFiled: February 17, 2020Publication date: August 27, 2020Inventors: Eoin E. English, Andrew William Sparks, Scott Robert Davis, Tyler Adam Dunn, Maurizio Zecchini, Michael Ziemkiewicz, Ronald A. Kapusta, Javier Calpe Maravilla, Paul O'Sullivan, Jonathan Ephraim David Hurwitz, Erik D. Barnes, Monica Redon Segrera, krystian Balicki
-
Patent number: 10725959Abstract: SPI Round Robin Mode for Single-Cycle MUX Channel Sequencing. SPI round robin mode is an SPI mode applicable for MUX devices control. It allows the MUX output to connect to the next input channel sequentially in just one clock cycle. Configurations can be made such as: clock edge to use (rising/falling), ascending/descending channel sequence, and enabling/disabling the channels to go through. The device supersedes an ADC with built in sequencing and is applicable to multiplexing, switching, instrumentation, process control and isolation application—while retaining SPI device control and operation.Type: GrantFiled: March 11, 2019Date of Patent: July 28, 2020Assignee: Analog Devices Global Unlimited Company, Inc.Inventors: David Aherne, Jofrey Santillan, Wes Vernon Lofamia, Paul O'Sullivan, Padraig McDaid
-
Patent number: 10714923Abstract: In electronic systems, the downstream circuitry may be damaged by overcurrent and overvoltage events. Therefore, there is provided a dual protection device for protecting electrical components in electronic systems. The protection device includes a mechanical fuse in conjunction with an electronic fuse, eFuse, the two components connected in series, together protecting against overcurrent events on two levels. The mechanical fuse provides high overcurrent protection, realising fast and reliable protection at high overcurrent events, and the electronic fuse provides low overcurrent protection, realising accurate and resettable protection for low overcurrent events.Type: GrantFiled: November 29, 2018Date of Patent: July 14, 2020Assignee: Analog Devices Internatianal Unlimited CompanyInventors: Paul O'Sullivan, Maurice O'Brien, Donal G. O'Sullivan
-
Patent number: 10691926Abstract: The present disclosure relates to performing facial recognition using a single-pixel sensor that measures the time signature of a light pulse reflected from a subjects face. Due to depth differences between the sensor position and different parts of the subject's face reflections of a short duration illumination pulse from the different parts of the subject's face will arrive back at the sensor at different times, thus providing a time-based one-dimensional signature unique to the individual subject. By analyzing the reflection signature using neural networks or principal component analysis (PCA), recognition of the subject can be obtained. In addition, the same system may also be used to recognize or discriminate between any other objects of known shape in addition to faces, for example manufactured products on a production line, or the like.Type: GrantFiled: May 3, 2018Date of Patent: June 23, 2020Assignee: ANALOG DEVICES, INC.Inventors: Maurizio Zecchini, Paul O'Sullivan, Chao Wang
-
Publication number: 20200176969Abstract: In electronic systems, the downstream circuitry may be damaged by overcurrent and overvoltage events. Therefore, there is provided a dual protection device for protecting electrical components in electronic systems. The protection device includes a mechanical fuse in conjunction with an electronic fuse, eFuse, the two components connected in series, together protecting against overcurrent events on two levels. The mechanical fuse provides high overcurrent protection, realising fast and reliable protection at high overcurrent events, and the electronic fuse provides low overcurrent protection, realising accurate and resettable protection for low overcurrent events.Type: ApplicationFiled: November 29, 2018Publication date: June 4, 2020Inventors: Paul O'Sullivan, Maurice O'Brien, Donal G. O'Sullivan
-
Publication number: 20200176974Abstract: Digital isolator devices, and many other devices, have a maximum device junction temperature, which, if exceeded, may cause device failure and the integrity of the isolation is no longer guaranteed. The use of an electronic fuse, eFuse, arranged in series with the digital isolator, provides a protection scheme for the digital isolator in which current is limited by the eFuse when it is determined that the supply current of the digital isolator exceeds a predetermined threshold that would the cause junction temperature to increase above an absolute maximum rating. As such, the integrity of the digital isolator is preserved in the event of a system fault.Type: ApplicationFiled: November 29, 2018Publication date: June 4, 2020Inventors: Paul O'Sullivan, Maurice O'Brien, Donal G. O'Sullivan, Stefan Hacker, Conal Watterson
-
Publication number: 20190340418Abstract: The present disclosure relates to performing facial recognition using a single-pixel sensor that measures the time signature of a light pulse reflected from a subjects face. Due to depth differences between the sensor position and different parts of the subject's face reflections of a short duration illumination pulse from the different parts of the subject's face will arrive back at the sensor at different times, thus providing a time-based one-dimensional signature unique to the individual subject. By analyzing the reflection signature using neural networks or principal component analysis (PCA), recognition of the subject can be obtained. In addition, the same system may also be used to recognize or discriminate between any other objects of known shape in addition to faces, for example manufactured products on a production line, or the like.Type: ApplicationFiled: May 3, 2018Publication date: November 7, 2019Applicant: Analog Devices, Inc.Inventors: Maurizio ZECCHINI, Paul O'SULLIVAN, Chao WANG
-
Publication number: 20190278736Abstract: SPI Round Robin Mode for Single-Cycle MUX Channel Sequencing. SPI round robin mode is an SPI mode applicable for MUX devices control. It allows the MUX output to connect to the next input channel sequentially in just one clock cycle. Configurations can be made such as: clock edge to use (rising/falling), ascending/descending channel sequence, and enabling/disabling the channels to go through. The device supersedes an ADC with built in sequencing and is applicable to multiplexing, switching, instrumentation, process control and isolation application—while retaining SPI device control and operation.Type: ApplicationFiled: March 11, 2019Publication date: September 12, 2019Applicant: Analog Devices Global Unlimited CompanyInventors: David AHERNE, Jofrey SANTILLAN, Wes Vernon LOFAMIA, Paul O'SULLIVAN, Padraig McDAID
-
Publication number: 20190203300Abstract: New methods for treating patents for urothelial cancer (UC) include combining selected phenotypic variables with levels of genotypic expression into a metric, the “G+P INDEX.” The G+P INDEX combines age, sex, smoking history, presence of hematuria, and frequency of hematuria with genotypic expression of the genetic markers, MDK, CDC2, HOXA13, IGFBP5, and optionally IL8Rb, then determining of the G+P INDEX value obtained for a patient is within one of three groups, either: (1) at High Risk of UC, (2) at Risk of UC, or (3) at Low Risk of UC. For groups 1 and 2, further clinical and laboratory work up or treatment is indicated, and patients in group 3 are monitored periodically to determine the need for further clinical workup. Using the G+P INDEX can save substantial time, effort, and funds by avoiding unnecessary medical diagnostic procedures for patients having or are at risk for developing UC.Type: ApplicationFiled: November 19, 2018Publication date: July 4, 2019Applicant: Pacific Edge LimitedInventors: David Darling, James Miller Suttie, Mark Dalphin, Laimonis Kavalieris, Paul O'Sullivan, Satish Kumar
-
Publication number: 20180342050Abstract: There is presented a system and method for detecting mobile device fault conditions, including detecting fault conditions by software operating on the mobile device. In one embodiment, the present invention provides for systems and methods for using a neural network to detect, from an image of the device, that the mobile device has a defect, for instance a cracked or scratched screen. Systems and methods also provide for, reporting the defect status of the device, working or not, so that appropriate action may be taken by a third party.Type: ApplicationFiled: February 19, 2018Publication date: November 29, 2018Applicant: YOUGETITBACK LimitedInventors: William Fitzgerald, Donal O'Shaughnessy, Donie Kelly, Paul O'Sullivan, Liam O'Callaghan, James Donavan, Shane Hallinan, Charlie McGrory, Wayne Morgan, Uday Chitturi, Patrick Conway, John Mollaghan, Kevin Sutton
-
Patent number: 10131955Abstract: New methods for identifying patents with hematuria who are at low risk of having urothelial cancer (UC) include combining selected phenotypic variables with levels of genotypic expression into a new metric, the “G+P INDEX.” The G+P INDEX combines age, sex, smoking history, presence of hematuria, and frequency of hematuria with genotypic expression of the genetic markers, MDK, CDC2, HOXA13, IGFBP5, and optionally IL8Rb, then determining of the G+P INDEX value obtained for a patient is within one of three groups, either: (1) at High Risk of UC, (2) at Risk of UC, or (3) at Low Risk of UC. For groups 1 and 2, further clinical and laboratory work up is indicated, and patients in group 3 are monitored periodically to determine the need for further clinical workup. Using the G+P INDEX can save substantial time, effort, and funds by avoiding unnecessary medical diagnostic procedures for patients at Low Risk of UC.Type: GrantFiled: May 19, 2016Date of Patent: November 20, 2018Assignee: PACIFIC EDGE LIMITEDInventors: David Darling, James Miller Suttie, Mark Dalphin, Laimonis Kavalieris, Paul O'Sullivan, Satish Kumar
-
Publication number: 20180298452Abstract: Embodiments of this invention include methods for detection of markers of bladder cancer and inflammatory conditions of the bladder. Particularly, methods include detection of expression of certain genetic markers for bladder cancer and markers for detection of inflammatory conditions of the bladder. These methods provide improved detection of the markers, and provide better detection of bladder cancer and inflammatory conditions of the bladder.Type: ApplicationFiled: May 24, 2018Publication date: October 18, 2018Applicant: Pacific Edge LimitedInventors: Parry John Guilford, Mark Dalphin, Laimonis Kavalieris, Paul O'Sullivan
-
Patent number: 9982305Abstract: This invention relates to the use of human neutrophil marker interleukin 8 receptor B (IL8Rb) for detection of bladder cancer, and more particularly to the use of EL8Rb for discriminating between transitional cell carcinoma of the bladder (TCC) and inflammatory conditions of the bladder.Type: GrantFiled: November 11, 2011Date of Patent: May 29, 2018Assignee: PACIFIC EDGE LIMITEDInventors: Parry John Guilford, Mark Dalphin, Laimonis Kavalieris, Paul O'Sullivan
-
Publication number: 20170275697Abstract: New methods for identifying patents with hematuria who are at low risk of having urothelial cancer (UC) include combining selected phenotypic variables with levels of genotypic expression into a new metric, the “G+P INDEX.” The G+P INDEX combines age, sex, smoking history, presence of hematuria, and frequency of hematuria with genotypic expression of the genetic markers, MDK, CDC2, HOXA13, IGFBP5, and optionally IL8Rb, then determining of the G+P INDEX value obtained for a patient is within one of three groups, either: (1) at High Risk of UC, (2) at Risk of UC, or (3) at Low Risk of UC. For groups 1 and 2, further clinical and laboratory work up is indicated, and patients in group 3 are monitored periodically to determine the need for further clinical workup. Using the G+P INDEX can save substantial time, effort, and funds by avoiding unnecessary medical diagnostic procedures for patients at Low Risk of UC.Type: ApplicationFiled: May 19, 2016Publication date: September 28, 2017Applicant: Pacific Edge LimitedInventors: David Darling, James Miller Suttie, Mark Dalphin, Laimonis Kavalieris, Paul O'Sullivan, Satish Kumar